December 4, 2023

An Austin-based biopharmaceutical company focused on treating Alzheimer’s disease is under scrutiny after a report leaked with claims of data manipulation. Company officials dispute the allegations. Its stock plummeted late this week — click through for the latest.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *